back to overview
GENERATION HD2
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals With…
Chan Zuckerberg Initiative funds project by Dr. Sabine Krabbe.
Bonn/Germany, November 10, 2023. Neurodegenerative diseases like Alzheimer’s and Parkinson’s can be associated to depression and…
Gaining Knowledge in Virtual Spaces
Through a project funded with three million euros by the Ministry of Culture and Science of North-Rhine Westphalia (NRW), scientists in Bonn and Dortmund aim…
Our strategic partners
Contact
technologietransfer@dzne.de
Industry Cooperations
The fight against neurodegenerative diseases cannot be achieved without strong partners. Teaming up with…
European Research Council awards “Starting Grant” to Dr. Dragomir Milovanovic.
Berlin/Germany, November 6, 2023. Dr. Dragomir Milovanovic, a neuroscientist at DZNE’s Berlin site, has been awarded an…
Publication in the scientific journal CELL.
Berlin/Germany, November 2, 2023. Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
